197 related articles for article (PubMed ID: 34720999)
1. Curcumin Reduced H
Zhang J; Li K; Wang X; Smith AM; Ning B; Liu Z; Liu C; Ross CA; Smith WW
Front Aging Neurosci; 2021; 13():754956. PubMed ID: 34720999
[TBL] [Abstract][Full Text] [Related]
2. The Parkinson's disease-associated mutation LRRK2 G2385R alters mitochondrial biogenesis via the PGC-1α-TFAM pathway.
Xue J; Zhang J; Zhang J; Liu J; Wang F; Li K; Liu C
Mitochondrion; 2023 Nov; 73():10-18. PubMed ID: 37708949
[TBL] [Abstract][Full Text] [Related]
3. Effect of a Leucine-rich Repeat Kinase 2 Variant on Motor and Non-motor Symptoms in Chinese Parkinson's Disease Patients.
Sun Q; Wang T; Jiang TF; Huang P; Li DH; Wang Y; Xiao Q; Liu J; Chen SD
Aging Dis; 2016 May; 7(3):230-6. PubMed ID: 27330837
[TBL] [Abstract][Full Text] [Related]
4. The G2385R variant of leucine-rich repeat kinase 2 associated with Parkinson's disease is a partial loss-of-function mutation.
Rudenko IN; Kaganovich A; Hauser DN; Beylina A; Chia R; Ding J; Maric D; Jaffe H; Cookson MR
Biochem J; 2012 Aug; 446(1):99-111. PubMed ID: 22612223
[TBL] [Abstract][Full Text] [Related]
5. The G2385R risk factor for Parkinson's disease enhances CHIP-dependent intracellular degradation of LRRK2.
Rudenko IN; Kaganovich A; Langston RG; Beilina A; Ndukwe K; Kumaran R; Dillman AA; Chia R; Cookson MR
Biochem J; 2017 Apr; 474(9):1547-1558. PubMed ID: 28320779
[TBL] [Abstract][Full Text] [Related]
6. Lack of association between LRRK2 G2385R and cognitive dysfunction in Korean patients with Parkinson's disease.
Hong JH; Kim YK; Park JS; Lee JE; Oh MS; Chung EJ; Kim JY; Sung YH; Lyoo CH; Lee JH; Kwon DY; Kim HS; Shin HW; Park SA; Park IS; Kim JS; Lee PH; Koh SB; Baik JS; Kim SJ; Ma HI; Kim JW; Kim YJ
J Clin Neurosci; 2017 Feb; 36():108-113. PubMed ID: 27839916
[TBL] [Abstract][Full Text] [Related]
7. The LRRK2 G2385R variant is a risk factor for sporadic Parkinson's disease in the Korean population.
Kim JM; Lee JY; Kim HJ; Kim JS; Shin ES; Cho JH; Park SS; Jeon BS
Parkinsonism Relat Disord; 2010 Feb; 16(2):85-8. PubMed ID: 19854095
[TBL] [Abstract][Full Text] [Related]
8. The association between the LRRK2 G2385R variant and the risk of Parkinson's disease: a meta-analysis based on 23 case-control studies.
Xie CL; Pan JL; Wang WW; Zhang Y; Zhang SF; Gan J; Liu ZG
Neurol Sci; 2014 Oct; 35(10):1495-504. PubMed ID: 25027012
[TBL] [Abstract][Full Text] [Related]
9. Brain-derived neurotrophic factor (BDNF) genetic polymorphism greatly increases risk of leucine-rich repeat kinase 2 (LRRK2) for Parkinson's disease.
Liu J; Zhou Y; Wang C; Wang T; Zheng Z; Chan P
Parkinsonism Relat Disord; 2012 Feb; 18(2):140-3. PubMed ID: 21924942
[TBL] [Abstract][Full Text] [Related]
10. G2385R and I2020T Mutations Increase LRRK2 GTPase Activity.
Ho DH; Jang J; Joe EH; Son I; Seo H; Seol W
Biomed Res Int; 2016; 2016():7917128. PubMed ID: 27314038
[TBL] [Abstract][Full Text] [Related]
11. LRRK2 enhances oxidative stress-induced neurotoxicity via its kinase activity.
Heo HY; Park JM; Kim CH; Han BS; Kim KS; Seol W
Exp Cell Res; 2010 Feb; 316(4):649-56. PubMed ID: 19769964
[TBL] [Abstract][Full Text] [Related]
12. LRRK2 G2385R variant carriers of female Parkinson's disease are more susceptible to motor fluctuation.
Gao C; Pang H; Luo XG; Ren Y; Shang H; He ZY
J Neurol; 2013 Nov; 260(11):2884-9. PubMed ID: 24046064
[TBL] [Abstract][Full Text] [Related]
13. Motor and nonmotor heterogeneity of LRRK2-related and idiopathic Parkinson's disease.
Marras C; Alcalay RN; Caspell-Garcia C; Coffey C; Chan P; Duda JE; Facheris MF; Fernández-Santiago R; Ruíz-Martínez J; Mestre T; Saunders-Pullman R; Pont-Sunyer C; Tolosa E; Waro B;
Mov Disord; 2016 Aug; 31(8):1192-202. PubMed ID: 27091104
[TBL] [Abstract][Full Text] [Related]
14. Olfactory Dysfunction in Parkinson's Disease Patients with the LRRK2 G2385R Variant.
Cao M; Gu ZQ; Li Y; Zhang H; Dan XJ; Cen SS; Li DW; Chan P
Neurosci Bull; 2016 Dec; 32(6):572-576. PubMed ID: 27699718
[TBL] [Abstract][Full Text] [Related]
15. The Association between
Di W; Zeng Z; Li J; Liu X; Bo M; Lv H
Parkinsons Dis; 2018; 2018():3418306. PubMed ID: 30123490
[TBL] [Abstract][Full Text] [Related]
16. The LRRK2 G2385R variant is a partial loss-of-function mutation that affects synaptic vesicle trafficking through altered protein interactions.
Carrion MDP; Marsicano S; Daniele F; Marte A; Pischedda F; Di Cairano E; Piovesana E; von Zweydorf F; Kremmer E; Gloeckner CJ; Onofri F; Perego C; Piccoli G
Sci Rep; 2017 Jul; 7(1):5377. PubMed ID: 28710481
[TBL] [Abstract][Full Text] [Related]
17. Effect of LRRK2 G2385R Variant on Subthalamic Deep Brain Stimulation Efficacy in Parkinson's Disease in a Han Chinese Population.
Chen S; Liu H; Wu QQ; Xu SJ; Li WG; Chen T; Li C; Ma XY; Xu S; Liu YM
Front Neurol; 2019; 10():1231. PubMed ID: 31824408
[TBL] [Abstract][Full Text] [Related]
18. Pathophysiological evaluation of the LRRK2 G2385R risk variant for Parkinson's disease.
Tezuka T; Taniguchi D; Sano M; Shimada T; Oji Y; Tsunemi T; Ikeda A; Li Y; Yoshino H; Ogata J; Shiba-Fukushima K; Funayama M; Nishioka K; Imai Y; Hattori N
NPJ Parkinsons Dis; 2022 Aug; 8(1):97. PubMed ID: 35931783
[TBL] [Abstract][Full Text] [Related]
19. Leucine-Rich Repeat Kinase (LRRK2) Genetics and Parkinson's Disease.
Monfrini E; Di Fonzo A
Adv Neurobiol; 2017; 14():3-30. PubMed ID: 28353276
[TBL] [Abstract][Full Text] [Related]
20. SNCA but not DNM3 and GAK modifies age at onset of LRRK2-related Parkinson's disease in Chinese population.
Yang ZH; Li YS; Shi MM; Yang J; Liu YT; Mao CY; Fan Y; Hu XC; Shi CH; Xu YM
J Neurol; 2019 Jul; 266(7):1796-1800. PubMed ID: 31041581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
